Jim L. Allen - 16 Dec 2022 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role
Director
Signature
/s/ David McClung, by power of attorney
Issuer symbol
BCDA
Transactions as of
16 Dec 2022
Net transactions value
+$249,999
Form type
4
Filing time
19 Dec 2022, 07:02:30 UTC
Previous filing
30 Sep 2022
Next filing
26 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCDA Common Stock Award $249,999 +148,809 +22% $1.68 830,531 16 Dec 2022 Direct F1
holding BCDA Common Stock 92 16 Dec 2022 See Footnote F2
holding BCDA Common Stock 92 16 Dec 2022 See Footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased from the Issuer in a private placement that closed on December 16, 2022.
F2 These shares are held in a custodial account for the benefit of a grandchild of the Reporting Person.